Helminth Infection During Pregnancy on Vitamin D Regulation: HELMVIT Study
HELMVIT
Assessing the Effect of Maternal Helminth Infection on Vitamin D Regulation and on the Immune System of the Infant
1 other identifier
observational
180
1 country
1
Brief Summary
Purpose: To examine whether helminth infection during pregnancy alters Vitamin-D-metabolism and reactivity of the child's immune system Hypothesis: Helminth infection during pregnancy is associated with altered Vitamin D levels and Vitamin D receptor expression in the placenta and modified immune reactivity in the infant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 28, 2019
CompletedFirst Submitted
Initial submission to the registry
March 25, 2020
CompletedFirst Posted
Study publicly available on registry
March 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedJune 18, 2023
April 1, 2023
3.9 years
March 25, 2020
June 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association between Schistosoma and helminth infection and Vitamin D levels.
Schistosoma hematobium in pregnancy is associated with vitamin D metabolism
48 Months
Secondary Outcomes (1)
Association between Schistosoma infection and intrauterine growth restriction (IUGR) (defined as birth weight below the 10th birth weight percentile), stillbirth and premature delivery.
48 Months
Study Arms (3)
S. haematobium positive
Pregnant women infected with Schistosoma hematobium alone
geohelminths positive
pregnant women infected with geohelminths alone
Helminth negative
Pregnant women free of anyn helminths infection
Interventions
Schistosomiasis is an acute and chronic parasitic disease caused by blood flukes (trematode worms) of the genus Schistosoma.Schistosomiasis is prevalent in tropical and subtropical areas, especially in poor communities without access to safe drinking water and adequate sanitation.
Soil-transmitted helminth infections are among the most common infections worldwide and affect the poorest and most deprived communities. They are transmitted by eggs present in human faeces which in turn contaminate soil in areas where sanitation is poor.
Eligibility Criteria
The target population is pregnant women coming to the ante natal clinics (ANC) for routine visits or to obtain medical care in the obstetrics department of the Albert Schweitzer Hospital (ASH) as well as at Georges Rawiri General Hospital (GRGH), both situated in Lambaréné. The pregnant women originally from areas endemic for Schistosomiasis and Soil-transmitted helminths will be invited to participate into the study.
You may qualify if:
- Pregnant women attending antenatal care from Lambaréné and Fougamou areas
- Pregnant women who have given written informed consent to the study for herself and for her unborn child and live infant.
You may not qualify if:
- Known of chronic infections and diseases(e.g. diabetes, HIV, Hepatitis B and C, anemia).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre de Recherche Médicale de Lambarénélead
- Technical University of Munichcollaborator
- University Hospital Tuebingencollaborator
Study Sites (1)
Josiane Y Honkpehedji
Lambaréné, Moyen-Ogooué Province, BP 242, Gabon
Biospecimen
S. haematobium will be assessed using urine filtration technique, intestinal parasites will be determined using the Kato-Katz method as well as different culture methods According to their infection status, women will be allocated to the following groups: S. haematobium positive, geohelminths positive and helminth negative participants. Plasma and peripheral blood mononuclear cells (PBMCs) are prepared and stored at -150°C; serum will be collected and immediately frozen in lightproof vials at -80 °C until further analysis.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayola A ADEGNIKA, MD, PhD
Centre de Recherche Médicale de Lambaréné
- STUDY CHAIR
Meral Esen, MD
University Hospital Tuebingen
- STUDY DIRECTOR
Clarissa DaCosta, MD
Technical University of Munich
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2020
First Posted
March 27, 2020
Study Start
January 28, 2019
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
June 18, 2023
Record last verified: 2023-04